ATE346923T1 - Ly6h-gen - Google Patents

Ly6h-gen

Info

Publication number
ATE346923T1
ATE346923T1 AT99943357T AT99943357T ATE346923T1 AT E346923 T1 ATE346923 T1 AT E346923T1 AT 99943357 T AT99943357 T AT 99943357T AT 99943357 T AT99943357 T AT 99943357T AT E346923 T1 ATE346923 T1 AT E346923T1
Authority
AT
Austria
Prior art keywords
gene
expression vector
product
ly6h
gen
Prior art date
Application number
AT99943357T
Other languages
English (en)
Inventor
Masato Horie
Keiichi Okutomi
Yoshihiro Taniguchi
Mikio Suzuki
Yutaka Ohbuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE346923T1 publication Critical patent/ATE346923T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AT99943357T 1998-09-17 1999-09-16 Ly6h-gen ATE346923T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26355098 1998-09-17

Publications (1)

Publication Number Publication Date
ATE346923T1 true ATE346923T1 (de) 2006-12-15

Family

ID=17391112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943357T ATE346923T1 (de) 1998-09-17 1999-09-16 Ly6h-gen

Country Status (17)

Country Link
US (4) US7432363B2 (de)
EP (1) EP1114861B8 (de)
JP (1) JP4403443B2 (de)
KR (1) KR100640265B1 (de)
CN (1) CN1240834C (de)
AT (1) ATE346923T1 (de)
AU (1) AU767878B2 (de)
BR (1) BR9913850A (de)
CA (1) CA2342770C (de)
CY (1) CY1107552T1 (de)
DE (1) DE69934239T8 (de)
DK (1) DK1114861T3 (de)
ES (1) ES2276531T3 (de)
HK (1) HK1038380A1 (de)
ID (1) ID29573A (de)
PT (1) PT1114861E (de)
WO (1) WO2000017345A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE346923T1 (de) * 1998-09-17 2006-12-15 Otsuka Pharma Co Ltd Ly6h-gen
CA2459161A1 (en) * 2001-08-31 2003-03-13 The Rockefeller University Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
CN102898519B (zh) 2005-11-30 2015-10-28 Abbvie公司 抗淀粉样β蛋白的单克隆抗体及其用途
EP2289909B1 (de) 2005-11-30 2014-10-29 AbbVie Inc. Screeningsverfahren, Verfahren zur Reinigung von nicht-diffundierenden Beta-Oligomeren, selektive Antikörper gegen genannten nichtdiffundierende Beta-Oligomere und Verfahren zur Herstellung von genannten Antikörpern
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
KR101508397B1 (ko) * 2007-02-22 2015-04-08 제넨테크, 인크. 염증성 장 질환의 검출 방법
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
EP2461673A4 (de) 2009-08-05 2013-08-07 Intra Cellular Therapies Inc Neue regulatorproteine und hemmer
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins
US20140286910A1 (en) * 2013-03-19 2014-09-25 Nikolai Tankovich Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity
CN105385754B (zh) * 2015-10-28 2018-11-06 北京泱深生物信息技术有限公司 一种与胆管癌相关的分子标记物
KR102232200B1 (ko) * 2019-03-13 2021-03-25 아주대학교산학협력단 알츠하이머치매 진단 바이오마커

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011912A (en) 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
JPH0348696A (ja) * 1989-07-14 1991-03-01 Toray Ind Inc ヒトリンパ球表面抗原およびそれをコードする遺伝子
WO1997018224A1 (en) * 1995-11-13 1997-05-22 Human Genome Sciences, Inc. Human stem cell antigen 2
CA2315617A1 (en) * 1997-12-31 1999-07-08 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
ATE346923T1 (de) * 1998-09-17 2006-12-15 Otsuka Pharma Co Ltd Ly6h-gen

Also Published As

Publication number Publication date
DE69934239T2 (de) 2007-06-28
KR100640265B1 (ko) 2006-10-31
CN1318099A (zh) 2001-10-17
ES2276531T3 (es) 2007-06-16
EP1114861A4 (de) 2004-10-13
CY1107552T1 (el) 2013-03-13
HK1038380A1 (en) 2002-03-15
PT1114861E (pt) 2007-01-31
CA2342770C (en) 2011-06-21
EP1114861A1 (de) 2001-07-11
ID29573A (id) 2001-09-06
EP1114861B8 (de) 2008-10-01
DK1114861T3 (da) 2007-03-19
CA2342770A1 (en) 2000-03-30
AU767878B2 (en) 2003-11-27
BR9913850A (pt) 2001-10-23
US20040254340A1 (en) 2004-12-16
US20080275218A1 (en) 2008-11-06
AU5651899A (en) 2000-04-10
WO2000017345A1 (fr) 2000-03-30
KR20010085801A (ko) 2001-09-07
JP4403443B2 (ja) 2010-01-27
CN1240834C (zh) 2006-02-08
EP1114861B1 (de) 2006-11-29
US20090017479A1 (en) 2009-01-15
US7582732B2 (en) 2009-09-01
DE69934239D1 (de) 2007-01-11
US7432363B2 (en) 2008-10-07
US20100261880A1 (en) 2010-10-14
DE69934239T8 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
CY1107552T1 (el) Ly6h γονιδιο
WO1999053061A3 (en) Tumor associated nucleic acids and uses therefor
DE69636866D1 (en) Reverse "two-hybrid"-systeme
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69839444D1 (de) Smad 6 und dessen anwendungen
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
WO2003011898A3 (fr) Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
WO2002004677A3 (en) Methods for diagnosis and treatment of psychiatric disorders
WO2000003004A3 (en) Presenilin 2 specific ribozyme
WO1997002730A3 (en) Enamel matrix related polypeptide
WO2001059120A3 (en) Il-17 like molecules and uses thereof
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
EP1090995A3 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
WO2004003170A3 (en) Agents capable of inhibiting ras and uses thereof
WO2000008143A3 (de) Gen isoliert auf dem kurzen arm des menschlichen chromosoms 17
WO2003000717A3 (de) Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
WO2002000827A3 (fr) Nouveau polypeptide, proteine de methylation d'adn-cysteine methyl-transferase 10, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1114861

Country of ref document: EP